Descriptive Epidemiology of Myelodysplastic Syndromes

  • C. Aul
  • N. Gattermann
  • W. Schneider
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 36)


Myelodysplastic syndromes (MDS) are clonal bone marrow disorders, characterized by quantitative and qualitative changes within hematopoietic cell lines. It is now generally accepted that they arise from neoplastic transformation of a multipotent hematopoietic progenitor cell. Findings in conformity with the malignant character of MDS are the frequent excess of blast cells in the bone marrow, the occasional occurrence of Auer rods [1], the defective ‘leukemic’ in vitro growth pattern of granulomonopoietic progenitor cells [2] and the presence of characteristic chromosomal abnormalities [3].


Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndrome Hematopoietic Cell Line Bone Marrow Specimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aul C, Gattermann N, Heyll A, Germing U, Schneider W (1992) Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6: 52–59PubMedGoogle Scholar
  2. 2.
    Gattermann N, Aul C, Schneider W (1990) Two types of acquired idiopathic sideroblastic anaemia (AISA). Br J Haematol 74: 45–52PubMedCrossRefGoogle Scholar
  3. 3.
    Heim S (1992) Cytogenetic findings in primary and secondary MDS. Leuk Res 16: 43–36PubMedCrossRefGoogle Scholar
  4. 4.
    World Health Organization (1977) International classification of diseases: 9th revision. World Health Organization, GenevaGoogle Scholar
  5. 5.
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199PubMedGoogle Scholar
  6. 6.
    Linman JW, Bagby GC (1978) The preleukemic syndrome (hemopoietic dysplasia). Cancer 42: 854–864PubMedCrossRefGoogle Scholar
  7. 7.
    Devesa SS, Silverman DT, Young JL, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF (1987) Cancer incidence and mortality trends among whites in the United States, 1947–84 J Natl Cancer Inst 79: 701–745Google Scholar
  8. 8.
    Oscier DG (1987) Myelodysplastic syndromes. Bailliére’s Clin Haematol 1: 389–426CrossRefGoogle Scholar
  9. 9.
    Aul C, Fischer JT, Schneider W (1984) Diagnostik der myelodysplastischen Syndrome (“Präleukämien”). Dtsch Med Wochenschr 109: 506–510PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • C. Aul
    • 1
  • N. Gattermann
    • 1
  • W. Schneider
    • 1
  1. 1.Department of Internal Medicine, Hematology and Oncology DivisionHeinrich Heine UniversityDüsseldorf 2Germany

Personalised recommendations